{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:43Z","timestamp":1792032943656,"version":"4.4.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Many centers use universal antifungal prophylaxis after lung transplant, but risk factors for invasive fungal infection (IFI) in this setting are poorly described.\u00ad<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective, single-center cohort study including 603 lung transplant recipients assessed risk factors for early (within 90 days of transplant) invasive candidiasis (IC) and invasive mold infection (IMI) and late (90\u2013365 days after transplant) IMI using Cox proportional hazard regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In this cohort, 159 (26.4%) patients had 182 IFIs. Growth of yeast on donor culture (hazard ratio [HR], 3.30; 95% CI, 1.89\u20135.75) and prolonged length of stay (HR, 1.02; 95% CI, 1.01\u20131.03) were associated with early IC risk, whereas transplantation in 2016 or 2017 (HR, 0.21; 95% CI, 0.06\u20130.70; HR, 0.25; 95% CI, 0.08\u20130.80, respectively) and female recipient sex (HR, 0.53; 95% CI, 0.30\u20130.93) were associated with reduced risk. Antimold therapy (HR, 0.21; 95% CI, 0.06\u20130.78) was associated with lower early IMI risk, and female donor sex (HR, 0.40; 95% CI, 0.22\u20130.72) was associated with lower late IMI risk. Recent rejection was a risk factor for late IMI (HR, 1.73; 95% CI, 1.02\u20132.95), and renal replacement therapy predisposed to early IC, early IMI, and late IMI (HR, 5.67; 95% CI, 3.01\u201310.67; HR, 7.54; 95% CI, 1.93\u201329.45; HR, 5.33; 95% CI, 1.46\u201319.49, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In lung transplant recipients receiving universal antifungal prophylaxis, risk factors for early IC, early IMI, and late IMI differ.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad640","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T23:41:33Z","timestamp":1703029293000},"source":"Crossref","is-referenced-by-count":8,"title":["Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal Prophylaxis"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9529-036X","authenticated-orcid":false,"given":"Jonathan P","family":"Huggins","sequence":"first","affiliation":[{"name":"Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA"},{"name":"School of Medicine, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arthur","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shein-Chung","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pease","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA"},{"name":"School of Medicine, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stanly","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA"},{"name":"School of Medicine, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Workman","sequence":"additional","affiliation":[{"name":"Sentara Healthcare , Norfolk, Virginia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA"},{"name":"School of Medicine, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara D","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center , Durham, North Carolina , USA"},{"name":"School of Medicine, Duke University , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"2024021622362855300_ofad640-B1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.15677","article-title":"OPTN\/SRTR 2018 annual data report: lung","volume":"20","author":"Valapour","year":"2020","journal-title":"Am J Transplant"},{"key":"2024021622362855300_ofad640-B2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","author":"Doligalski","year":"2014","journal-title":"Am J Transplant"},{"key":"2024021622362855300_ofad640-B3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024021622362855300_ofad640-B4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MCP.0b013e3282f9b1d1","article-title":"Fungal infections in lung transplant recipients","volume":"14","author":"Silveira","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"2024021622362855300_ofad640-B5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.healun.2013.08.007","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report\u20132013; focus theme: age","volume":"32","author":"Yusen","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/tid.12613","article-title":"The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"18","author":"Andes","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"2024021622362855300_ofad640-B7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024021622362855300_ofad640-B9","doi-asserted-by":"crossref","first-page":"e13623","DOI":"10.1111\/ctr.13623","article-title":"Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin Transplant"},{"key":"2024021622362855300_ofad640-B10","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"key":"2024021622362855300_ofad640-B11","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B12","doi-asserted-by":"crossref","first-page":"e13085","DOI":"10.1111\/tid.13085","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia","volume":"21","author":"Chang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2024021622362855300_ofad640-B13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.idc.0000230548.96251.70","article-title":"Aspergillus infections after lung transplantation","volume":"14","author":"Day","year":"2006","journal-title":"Infect Dis Clin Pract"},{"key":"2024021622362855300_ofad640-B14","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3760\/cma.j.issn.0366-6999.20130252","article-title":"Pneumonia relevant to lung transplantation and pathogen distribution","volume":"126","author":"He","year":"2013","journal-title":"Chin Med J"},{"key":"2024021622362855300_ofad640-B15","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/TP.0000000000000743","article-title":"The effectiveness of culture-directed preemptive anti-Aspergillus treatment in lung transplant recipients at one year after transplant","volume":"99","author":"Hosseini-Moghaddam","year":"2015","journal-title":"Transplantation"},{"key":"2024021622362855300_ofad640-B16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.healun.2018.02.006","article-title":"A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture","volume":"37","author":"Husain","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.healun.2021.09.014","article-title":"Risk factors of invasive fungal infections in lung transplant recipients: a systematic review and meta-analysis","volume":"41","author":"Phoompoung","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2024021622362855300_ofad640-B19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"2024021622362855300_ofad640-B20","doi-asserted-by":"crossref","first-page":"e0028322","DOI":"10.1128\/aac.00283-22","article-title":"Safety of inhaled amphotericin B lipid complex as antifungal prophylaxis in lung transplant recipients","volume":"66","author":"Huggins","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024021622362855300_ofad640-B21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024021622362855300_ofad640-B22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/ciz156","article-title":"Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis","volume":"70","author":"Baker","year":"2020;","journal-title":"Clin Infect Dis"},{"key":"2024021622362855300_ofad640-B23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis","volume":"29","author":"Chong","year":"2015","journal-title":"Clin Transplant"},{"key":"2024021622362855300_ofad640-B24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1592\/phco.31.6.537","article-title":"Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center","volume":"31","author":"Pinney","year":"2011","journal-title":"Pharmacotherapy"},{"key":"2024021622362855300_ofad640-B25","first-page":"139","article-title":"Risk factors for candidemia in non-neutropenic critical patients in Colombia","volume":"40","author":"Ruiz","year":"2016","journal-title":"Med Intensiva"},{"key":"2024021622362855300_ofad640-B26","doi-asserted-by":"crossref","first-page":"e036452","DOI":"10.1136\/bmjopen-2019-036452","article-title":"Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"BMJ Open"},{"key":"2024021622362855300_ofad640-B27","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3201\/eid2810.220391","article-title":"Demographic and socioeconomic factors associated with fungal infection risk, United States, 2019","volume":"28","author":"Rayens","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024021622362855300_ofad640-B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid2301.161198","article-title":"Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002\u20132012","volume":"23","author":"Strollo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2024021622362855300_ofad640-B29","doi-asserted-by":"crossref","first-page":"e04437","DOI":"10.1016\/j.heliyon.2020.e04437","article-title":"Effect of testosterone and estrogen supplementation on the resistance to systemic Candida albicans infection in mice","volume":"6","author":"Arroyo-Mendoza","year":"2020","journal-title":"Heliyon"},{"key":"2024021622362855300_ofad640-B30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/myc.13449","article-title":"Let's talk about sex characteristics\u2014as a risk factor for invasive fungal diseases","volume":"65","author":"Egger","year":"2022","journal-title":"Mycoses"},{"key":"2024021622362855300_ofad640-B31","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.21037\/jtd-2021-26","article-title":"Fungal infections in lung transplantation","volume":"13","author":"Samanta","year":"2021","journal-title":"J Thorac Dis"},{"key":"2024021622362855300_ofad640-B32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1034\/j.1399-3062.2001.003003161.x","article-title":"Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies","volume":"3","author":"Gordon","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"2024021622362855300_ofad640-B33","doi-asserted-by":"crossref","first-page":"e930117","DOI":"10.12659\/AOT.930117","article-title":"Invasive fungal infections after liver transplantation: a retrospective matched controlled risk analysis","volume":"26","author":"Karadag","year":"2021","journal-title":"Ann Transplant"},{"key":"2024021622362855300_ofad640-B34","doi-asserted-by":"crossref","first-page":"e13714","DOI":"10.1111\/tid.13714","article-title":"Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients","volume":"23","author":"Yetmar","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2024021622362855300_ofad640-B35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/ajt.16935","article-title":"Risk factors of invasive fungal infections in liver transplant recipients: a systematic review and meta-analysis","volume":"22","author":"Phoompoung","year":"2022","journal-title":"Am J Transplant"},{"key":"2024021622362855300_ofad640-B36","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad640\/54758141\/ofad640.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad640\/56672576\/ofad640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/2\/ofad640\/56672576\/ofad640.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T22:36:58Z","timestamp":1708123018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad640\/7479793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad640","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,12,19]]},"article-number":"ofad640"}}